These results might partly explain the pro-tumor effects of serum PGD2 and further detailed investigations are needed to illuminate the mechanism of PGD2-CRTH2 in the development of DLBCL. The gene discussed is PTGDR2; the disease is diffuse large B-cell lymphoma.